Urinary biomarkers in prostate cancer: to the miRnome and beyond

We thank the Translational Andrology and Urology (TAU) editors for providing us this opportunity to reply to the insightful commentary by Conner et al. on our article “Temporal stability and prognostic biomarker potential of the prostate cancer urine transcriptome” (1). Liquid biopsies are one path leading to the future of personalized medicine.